Budolfi Privathospital I/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 15.9% 1.7% 7.1% 22.6%  
Credit score (0-100)  0 12 71 33 3  
Credit rating  N/A BB A BBB B  
Credit limit (kDKK)  0.0 0.0 5.9 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 266 5,312 6,436 12,840  
EBITDA  0.0 108 3,057 -2,148 -5,857  
EBIT  0.0 108 3,053 -2,160 -5,989  
Pre-tax profit (PTP)  0.0 108.0 3,000.0 -2,086.5 -6,107.5  
Net earnings  0.0 108.0 3,000.0 -2,086.5 -6,107.5  
Pre-tax profit without non-rec. items  0.0 108 3,000 -2,086 -6,107  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 23.0 108 1,134  
Shareholders equity total  0.0 108 3,108 1,021 -7,281  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 7,482  
Balance sheet total (assets)  0.0 996 5,422 6,905 7,289  

Net Debt  0.0 0.0 -2,832 -3,943 7,482  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 266 5,312 6,436 12,840  
Gross profit growth  0.0% 0.0% 1,897.0% 21.2% 99.5%  
Employees  0 0 3 15 26  
Employee growth %  0.0% 0.0% 0.0% 400.0% 73.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 996 5,422 6,905 7,289  
Balance sheet change%  0.0% 0.0% 444.4% 27.3% 5.6%  
Added value  0.0 108.0 3,057.0 -2,155.9 -5,856.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 19 73 894  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 -1.0 -2.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 40.6% 57.5% -33.6% -46.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 10.8% 95.1% -32.9% -55.8%  
ROI %  0.0% 100.0% 189.9% -98.2% -140.8%  
ROE %  0.0% 100.0% 186.6% -101.1% -147.0%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 10.8% 57.3% 14.8% -50.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -92.6% 183.6% -127.8%  
Gearing %  0.0% 0.0% 0.0% 0.0% -102.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 3.2%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 1.1 2.3 1.0 0.5  
Current Ratio  0.0 1.1 2.3 1.2 0.6  
Cash and cash equivalent  0.0 0.0 2,832.0 3,942.9 0.0  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 108.0 3,085.0 913.0 -4,708.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 1,019 -144 -225  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 1,019 -143 -225  
EBIT / employee  0 0 1,018 -144 -230  
Net earnings / employee  0 0 1,000 -139 -235